[Pharmacokinetics of rifampicin in single and repeated administration to patients with inflammatory processes in the lungs of nontuberculotic etiology].
Rifampicin is a broad spectrum semisynthetic antibiotic of the group of rifampicins. It is active against both grampositive and gramnegative organisms and mycobacteria. The studies on the pharmacokinetics of rifampicin showed that the drug was well absorbed from the gastro-intestinal tract. After a single administration of rifampicin in a dose of 150 mg its maximum concentration in the blood was registered in an hour. This concentration was preserved at the therapeutic level for 5 hours. Practically no accumulation of rifampicin was observed in its use in a dose of 150 mg 4 times a day for 5 days. Perspectivity of rifampicin use in the treatment of patients with inflammatory processes in the lungs of non-tuberculosis etiology was shown.
D000284:Administration, Oral; D000328:Adult; D001702:Biopharmaceutics; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007700:Kinetics; D008171:Lung Diseases / Q000188:drug therapy*; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage*; D013997:Time Factors
D012293:Rifampin
Farmakokinetika rifampitsina pri odnokratnom i povtornom vvedenii bol'nym s vospalitel'nymi protsessami netuberkuleznoi étiologii v legkikh